Good morning, everybody, and welcome to the health committee. It's great to see everybody here this morning. Pursuant to Standing Order 108(2) we're studying technological innovation.
We have very credible witnesses with us today, very distinguished witnesses.
From the Department of Health, we have Barbara Sabourin, director general. Is that Dr. Sabourin?